Posts tagged Axis Bank
Latest Research Reports On Stocks By Leading Brokerages: If you have any research reports that you would like to share with us, please send it to michael@rakesh-jhunjhunwala.in or to admin@rakesh-jhunjhunwala.in. (The pre-June 2016 reports are available here).
| AXIS Bank is on track to deliver steady performance. Buy for target price of Rs 1195 (35% upside): HDFC Securities | |
| Company: | Axis Bank |
| Brokerage: | HDFC Sec |
| Date of report: | November 25, 2022 |
| Type of Report: | Result Update |
| Recommendation: | Buy |
| Upside Potential: | 35% |
| Summary: | AXSB finally seems to be on track to deliver steady performance with lower shocks. While the bank is on track to deliver ~14-15% RoE over the next couple of years, we argue that enhanced productivity and gradual exercising of pricing power in chosen segments could drive sustained medium-term RoEs. We argue for a gradual convergence in valuation multiples with ICICIBC |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | HDFC Sec |
| 5 Stocks To Buy For 53% Gain In 2018-19 | |
| Company: | Aurobindo Pharma, Axis Bank, Firstsource Solutions Ltd, Muthoot Finance, PVR Ltd |
| Brokerage: | Edelweiss |
| Date of report: | November 13, 2018 |
| Type of Report: | Model Portfolio |
| Recommendation: | Buy |
| Upside Potential: | 53% |
| Summary: | Edelweiss Professional Investor Research |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | Aurobindo Pharma, Edelweiss, Firstsource Solutions Ltd, Muthoot Finance, PVR Ltd |